These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12919325)

  • 1. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
    Foley SF; van Vlijmen HW; Boynton RE; Adkins HB; Cheung AE; Singh J; Sanicola M; Young CN; Wen D
    Eur J Biochem; 2003 Sep; 270(17):3610-8. PubMed ID: 12919325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into the interaction between the Cripto CFC domain and the ALK4 receptor.
    Calvanese L; Saporito A; Oliva R; D' Auria G; Pedone C; Paolillo L; Ruvo M; Marasco D; Falcigno L
    J Pept Sci; 2009 Mar; 15(3):175-83. PubMed ID: 19035567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical synthesis of mouse cripto CFC variants.
    Marasco D; Saporito A; Ponticelli S; Chambery A; De Falco S; Pedone C; Minchiotti G; Ruvo M
    Proteins; 2006 Aug; 64(3):779-88. PubMed ID: 16752415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation and early cardiogenesis.
    Colas JF; Schoenwolf GC
    Gene; 2000 Sep; 255(2):205-17. PubMed ID: 11024280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto.
    Lohmeyer M; Harrison PM; Kannan S; DeSantis M; O'Reilly NJ; Sternberg MJ; Salomon DS; Gullick WJ
    Biochemistry; 1997 Apr; 36(13):3837-45. PubMed ID: 9092813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of mouse Cripto CFC domain and its inactive variant Trp107Ala.
    Calvanese L; Saporito A; Marasco D; D'Auria G; Minchiotti G; Pedone C; Paolillo L; Falcigno L; Ruvo M
    J Med Chem; 2006 Nov; 49(24):7054-62. PubMed ID: 17125258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of small bicyclic peptide inhibitors of Cripto-1 activity.
    Iaccarino E; Calvanese L; Untiveros G; Falcigno L; D'Auria G; Latino D; Sivaccumar JP; Strizzi L; Ruvo M; Sandomenico A
    Biochem J; 2020 Apr; 477(8):1391-1407. PubMed ID: 32215602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
    Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
    Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC; Harrison CA; Vale W
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
    Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
    J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto localizes Nodal at the limiting membrane of early endosomes.
    Blanchet MH; Le Good JA; Oorschot V; Baflast S; Minchiotti G; Klumperman J; Constam DB
    Sci Signal; 2008 Nov; 1(45):ra13. PubMed ID: 19001664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
    Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM
    Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic.
    Aykul S; Parenti A; Chu KY; Reske J; Floer M; Ralston A; Martinez-Hackert E
    J Biol Chem; 2017 Mar; 292(10):4138-4151. PubMed ID: 28126904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the oxidative refolding mechanism of Cripto-1 CFC domain.
    Iaccarino E; Sandomenico A; Corvino G; Focà G; Severino V; Russo R; Caporale A; Raimondo D; D'Abramo M; Alba J; Chambery A; Ruvo M
    Int J Biol Macromol; 2019 Sep; 137():1179-1189. PubMed ID: 31295488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural investigations on the Nodal-Cripto binding: a theoretical and experimental approach.
    Calvanese L; Marasco D; Doti N; Saporito A; D'Auria G; Paolillo L; Ruvo M; Falcigno L
    Biopolymers; 2010 Nov; 93(11):1011-21. PubMed ID: 20629020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the EGF-CFC gene cripto in cell differentiation and embryo development.
    Minchiotti G; Parisi S; Liguori GL; D'Andrea D; Persico MG
    Gene; 2002 Apr; 287(1-2):33-7. PubMed ID: 11992720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucosylation of Cripto is required for its ability to facilitate nodal signaling.
    Schiffer SG; Foley S; Kaffashan A; Hronowski X; Zichittella AE; Yeo CY; Miatkowski K; Adkins HB; Damon B; Whitman M; Salomon D; Sanicola M; Williams KP
    J Biol Chem; 2001 Oct; 276(41):37769-78. PubMed ID: 11500501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro.
    Focà G; Iaccarino E; Focà A; Sanguigno L; Untiveros G; Cuevas-Nunez M; Strizzi L; Leonardi A; Ruvo M; Sandomenico A
    Biochimie; 2019 Mar; 158():246-256. PubMed ID: 30703478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.